Arcturus Therapeutics Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CVAC | F | CureVac N.V. | 0.73 | |
TAK | C | Takeda Pharmaceutical Company Limited | 0.14 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PPH | D | Market Vectors Pharmaceutical ETF | 4.43 | |
OZEM | D | Roundhill GLP-1 & Weight Loss ETF | 1.96 | |
GINX | D | SGI Enhanced Global Income ETF | 1.74 | |
FLCO | C | Franklin Liberty Investment Grade Corporate ETF | 1.02 | |
APIE | D | Trust for Professional Managers ActivePassive International Equity ETF | 0.76 |
Compare ETFs
- Arcturus Therapeutics
Arcturus Therapeutics is an American biotech company focused on the discovery, development and commercialization of therapeutics for rare diseases with focus on RNA. Arcturus has developed a novel, potent and safe RNA therapeutics platform called LUNAR, a proprietary lipid-enabled delivery system for RNA medicines including small interfering RNA, messenger RNA, gene editing, DNA, antisense, and microRNA oligotherapeutics.
The company's pipeline includes RNA therapeutics towards rare diseases such as ornithine transcarbamylase deficiency (OTCD), and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19, currently co-developed with Singaporean scientists at Duke–NUS Medical School.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles